Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Through this IDC and associated delivery orders, Amerisourcebergen is delivering a wide variety of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, infectious disease prevention, and general medical care. The delivery orders under this IDC do not have set-aside designations, indicating open competition. Amerisourcebergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, demonstrating its role as a key vendor for federal healthcare programs.
The delivery orders awarded to Amerisourcebergen through the DLA IDC cover a diverse array of pharmaceutical and medical products, including medications such as JANUVIA, WEGOVY, BIKTARVY, NARCAN, NURTEC ODT, COSENTYX, TRULICITY, CONCERTA ER, and various generic drugs and supplies. These delivery orders, with firm fixed-price arrangements, have completion dates through November 2024 and enable the DLA to efficiently procure essential healthcare commodities to support the medical needs of military personnel, veterans, and other federal beneficiaries.
Generated 2/27/25, 12:19 PM